Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Aspire Ventures, LLC is a venture capital firm based in Lancaster, Pennsylvania, dedicated to transforming healthcare through impact investment. Founded in partnership with Penn Medicine Lancaster General Health, Aspire Ventures launched the Aspire Ventures Precision Medicine Fund (AVP) in April 2018, with an initial commitment of $30 million and a target fund size of $300 million. The firm aims to fast-track the development of precision medicine technologies that leverage artificial intelligence (AI) and the Internet of Things (IoT) to provide affordable, individualized healthcare solutions.
Currently, Aspire Ventures manages a portfolio of 12 companies and operates within a unique ecosystem that supports ventures from ideation to market adoption. The firm collaborates closely with healthcare providers and technology partners to enhance the scalability and effectiveness of its investments. Aspire Ventures is positioned to address significant challenges in the healthcare sector, particularly in improving patient outcomes and reducing unnecessary treatments.
Aspire Ventures invests primarily in early-stage ventures within the healthcare sector, with a strong emphasis on technologies that utilize AI and IoT to enhance precision medicine. The firm targets investments at the pre-seed, seed, and seed-plus stages, focusing on companies that can demonstrate scalability and address critical healthcare challenges. Their investment strategy is designed to compress the typical development timeline for healthcare innovations from 10-15 years to approximately 5 years.
The firm’s unique structure includes a comprehensive ecosystem of strategic partnerships and accelerators, which facilitate each step of the venture development process. Aspire Ventures actively seeks founders who are committed to transforming healthcare through innovative solutions and who can leverage the firm’s resources and expertise to achieve market success.
Aspire Ventures has built a notable portfolio of companies that exemplify its focus on precision medicine and healthcare innovation. The following companies are part of their investment portfolio:
Essam Abadir: CEO of Aspire Ventures, brings extensive experience in healthcare investment and management.
Dan Mitchell: Vice President of Corporate Development, focuses on strategic partnerships and business development initiatives.
To pitch Aspire Ventures, founders should utilize the contact form on their website or email info@aspirevc.com. It is recommended to include a clear overview of the business model, market opportunity, and how the technology leverages AI or IoT in the pitch deck. Response times may vary, but founders should expect to hear back within a few weeks.
Aspire Ventures operates the Smart Health Innovation Lab, a healthcare technology accelerator that collaborates with various organizations to validate and integrate market-ready healthcare technologies through a 12-week certification program. This program is designed to help startups achieve insurance reimbursement and market adoption.
In April 2018, Aspire Ventures announced the launch of its Precision Medicine Fund (AVP), with a target size of $300 million. The firm continues to actively promote its mission to transform healthcare through precision medicine technologies, engaging with various stakeholders in the healthcare innovation space.
Q?
Aspire Ventures primarily invests in early-stage healthcare ventures that utilize AI and IoT technologies to enhance precision medicine.
Q?
To pitch Aspire Ventures, founders should visit their website at aspirevc.com and submit their proposals via the contact form or email at info@aspirevc.com.
Q?
Aspire Ventures differentiates itself through its unique ecosystem model that spans from ideation to reimbursement, providing health system data and clinical expertise directly to portfolio companies.
Q?
The firm focuses on investments within the United States, particularly in sectors related to healthcare, AI, IoT, and biotech.
Q?
Post-investment, Aspire Ventures is actively involved in supporting its portfolio companies through strategic partnerships and access to their proprietary A2I Platform.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.